<html class="anndoc" data-anndoc-version="2.0" data-origid="11527705" id="11527705" lang="" xml:lang="" xmlns="http://www.w3.org/1999/xhtml"><head><title>11527705</title></head><body><article><section data-type="article"><div class="content"><p id="title">Evolution of anti-HIV drug candidates. Part 3: Diarylpyrimidine (DAPY) analogues.</p><p id="abstract">The synthesis and anti-HIV-1 activity of a series of diarylpyrimidines (DAPYs) are described. Several members of this novel class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) are extremely potent against both wild-type and a panel of clinically significant single- and double-mutant strains of HIV-1.</p></div></section></article></body></html>